Determinants of lung function improvement with omalizumab in adults with allergic asthma

J Allergy Clin Immunol Pract. 2020 Jun;8(6):2068-2070. doi: 10.1016/j.jaip.2020.01.019. Epub 2020 Jan 22.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Asthmatic Agents* / therapeutic use
  • Asthma* / drug therapy
  • Humans
  • Lung
  • Omalizumab / therapeutic use
  • Respiratory Physiological Phenomena
  • Treatment Outcome

Substances

  • Anti-Asthmatic Agents
  • Omalizumab

Associated data

  • ClinicalTrials.gov/NCT01922037